CLINICALLY SIGNIFICANT PROSTATE CANCER
Clinical trials for CLINICALLY SIGNIFICANT PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new CLINICALLY SIGNIFICANT PROSTATE CANCER trials appear
Sign up with your email to follow new studies for CLINICALLY SIGNIFICANT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Double-Team biopsy could catch more dangerous prostate cancers
Diagnosis Recruiting nowThis study tests whether combining two advanced imaging techniques (micro-ultrasound and MRI) during prostate biopsy can find more aggressive cancers than the current standard approach. About 400 men with suspected prostate cancer will participate. The goal is to improve detectio…
Matched conditions: CLINICALLY SIGNIFICANT PROSTATE CANCER
Phase: NA • Sponsor: Salzburger Landeskliniken • Aim: Diagnosis
Last updated Jun 27, 2026 13:04 UTC
-
AI could spare thousands from unnecessary prostate biopsies
Diagnosis Recruiting nowThis study is testing whether an artificial intelligence (AI) model can accurately predict which prostate cancers are aggressive and need treatment. Researchers will combine MRI and ultrasound images with tissue samples from 3,000 men. The goal is to reduce unnecessary biopsies a…
Matched conditions: CLINICALLY SIGNIFICANT PROSTATE CANCER
Sponsor: Guangxi Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
New scan could slash unnecessary prostate biopsies
Diagnosis Recruiting nowThis study tests whether combining two types of scans (PET and MRI) before a prostate biopsy can more accurately find serious prostate cancers while avoiding unnecessary biopsies for low-risk cancers. About 167 men with suspected prostate cancer will receive the combined scan, an…
Matched conditions: CLINICALLY SIGNIFICANT PROSTATE CANCER
Phase: PHASE2 • Sponsor: IRCCS San Raffaele • Aim: Diagnosis
Last updated Jun 27, 2026 12:01 UTC
-
New blood test could spot dangerous prostate cancer without a biopsy
Diagnosis Recruiting nowThis study is testing a new blood test that looks for genetic material from tiny particles called exosomes to diagnose aggressive prostate cancer. The goal is to see if this test can accurately identify men who need a biopsy, avoiding unnecessary procedures. Researchers plan to e…
Matched conditions: CLINICALLY SIGNIFICANT PROSTATE CANCER
Sponsor: Xijing Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC
-
New scan could help men with Low-Risk prostate cancer avoid unnecessary biopsies
Diagnosis Recruiting nowThis study tests a new way of reading PSMA PET/CT scans, called the Istanbul PSMA PET/CT Criteria, to see if it can better identify which men with low-risk prostate cancer can safely choose active surveillance (monitoring instead of immediate treatment). The researchers will enro…
Matched conditions: CLINICALLY SIGNIFICANT PROSTATE CANCER
Sponsor: Istanbul University - Cerrahpasa • Aim: Diagnosis
Last updated Jun 26, 2026 16:59 UTC